Background
Radiation-induced otitis media with effusion (RI-OME) is a debilitating sequela in nasopharyngeal carcinoma (NPC) survivors, affecting up to 30–50% of patients post-radiotherapy. Chronic middle ear dysfunction arises from eustachian tube fibrosis, mucosal ciliary damage, and immune suppression, creating a niche for bacterial colonization. Despite its prevalence, the bacteriological profile of RI-OME and its clinical implications remain understudied. This multicenter prospective study by Chen et al. (2026) bridges this gap by correlating microbial patterns with recurrence risks, offering insights for targeted management.
Study Design
Cohort and Methods
The study enrolled 208 patients: 93 with RI-OME (post-NPC radiotherapy) and 115 with non-radiation-induced OME (NRI-OME). All underwent diagnostic tympanocentesis, with middle ear effusion (MEE) cultured for aerobic/anaerobic bacteria. RI-OME patients were monitored for 24 weeks post-procedure, with recurrence defined as symptomatic effusion requiring intervention. Multivariate logistic regression adjusted for demographics, effusion viscosity (mucoid vs. serous), and comorbidities.
Key Findings
Microbial Landscape
RI-OME patients exhibited a 4.8-fold higher bacterial culture positivity rate versus NRI-OME (OR=4.843, p=0.006), dominated by Pseudomonas aeruginosa, methicillin-resistant Staphylococcus aureus (MRSA), and Candida species. Mucoid effusions had 8.6× greater odds of bacterial detection (OR=8.553, p=0.002), suggesting biofilm formation.
Recurrence Dynamics
Early recurrence (≤4 weeks) was strongly associated with male sex (OR=12.120, p=0.002) and bacterial colonization (OR=10.239, p=0.035). However, these factors lost significance over 24 weeks, implying transient microbial influence. Notably, 68% of recurrences occurred within 4 weeks, aligning with post-radiation tissue vulnerability windows.
Expert Commentary
“The transient impact of bacteria on recurrence challenges current antibiotic stewardship,” notes Dr. L. Xie (co-author). “While early recurrence may reflect acute infection, long-term relapse likely stems from radiation-induced anatomical and immune dysfunction.” The study’s prospective design strengthens causality inference, though sample size limits subgroup analyses for rare pathogens.
Conclusion
RI-OME harbors distinct, resistant microbiomes that drive early—but not late—recurrence. Clinicians should prioritize tympanocentesis cultures in mucoid RI-OME cases yet remain cautious about prolonged antibiotics. Future trials should evaluate biofilm-targeted therapies combined with Eustachian tube rehabilitation.
Funding and Registration
Supported by the National Natural Science Foundation of China (Grant 82371145). ClinicalTrials.gov: NCT05293377.
